Table 1: Demographic and clinicopathological characteristics of patients and the statistical significance of the associations of these data with piR-36741 and piR-36707 gene expressions of the patients.
p value | ||||
Patients (n = 19) | piR-36741 | piR-36707 | ||
Gender | Male | 9 (47.4%) | 0.182 | 0.006 |
Female | 10 (52.6%) | |||
Age | 35-44 | 4 (21%) | 0.093 | 0.306 |
45-64 | 10 (52.7%) | |||
> 65 | 5 (26.3%) | |||
TNM staging | Stage I | 13 (68.4%) | 0.01 (between stage I and II) < 0.001 (between stage I and IV) | 0.037 (between stage I and IV) < 0.001 (between stage II and IV) |
Stage II | 3 (15.8%) | |||
Stage III | 1 (5.3%) | |||
Stage IV | 2 (10.5%) | |||
Fuhrman nuclear grade | Grade 2 | 13 (68.4%) | 0.036 (between grade 2 and 4) | < 0.001 (between grade 2 and 4) |
Grade 3 | 2 (10.5%) | |||
Grade 4 | 4 (21.1%) | |||
RBC count | Low | 4 (21%) | 0.042 (between low and normal RBC count) | 0.06 (between low and normal RBC count) |
Normal | 14 (73.7%) | |||
High | 1 (5.3%) | |||
RBC count | Low | 4 (21%) | 0.042 (between low and normal RBC count) | 0.06 (between low and normal RBC count) |
Normal | 14 (73.7%) | |||
High | 1 (5.3%) | |||
Hemoglobin count | Low | 7 (36.8%) | 0.08 | < 0.001 |
Normal | 12 (63.2%) |
(Abbreviations.TNM: Tumor Node Metastasis) (RBC count lower than 4 million/mm3 and hemoglobin count lower than 13 g/dl were considered as low).